ARTICLE
2 August 2023

"Natural Killers" Enhanced By 3D Printing

MC
Marks & Clerk
Contributor
Marks & Clerk is one of the UK’s foremost firms of Patent and Trade Mark Attorneys. Our attorneys and solicitors are wired directly into the UK’s leading business and innovation economies. Alongside this we have offices in 9 international locations covering the EU, Canada and Asia, meaning we offer clients the best possible service locally, nationally and internationally.
3D printing, also referred to as Additive Manufacturing, has many applications in a wide range of technologies. One of the most important of these is perhaps 3D bioprinting...
UK Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

3D printing, also referred to as Additive Manufacturing, has many applications in a wide range of technologies. One of the most important of these is perhaps 3D bioprinting, in which a digital file is used to create 3D structures formed from cells and biomaterials.

A recent article published by the Institution of Engineering and Technology highlights research into the use of 3D bioprinting to form hydrogel encapsulating "natural killer" (NK) cells. NK cells have the capacity to selectively kill cells, such as tumour cells, that are harmful to the human body.

The hydrogel was prepared using sodium alginate and gelatin, and the NK cells were added. A PROTEK (Korea Institute of Machinery and Materials) device was used to print a macroporous structure. After incubation, the thermally sensitive gelatin in the hydrogel was removed, generating interconnected micropores where the gelatin was released. The micropores acted to assist NK cell aggregation, and the macropores provided cell transport, enhancing the viability and functionality of the NK cells.

The research concludes that "compared with 2D suspension cells, 3D cultures in micro/macropore-forming hydrogels maintained the viability and tumor lytic activity of NK cells. The use of a pore-forming hydrogel provides advantages for the antitumor efficacy of immunotherapy in the tumor microenvironment".

Further information on this exciting use of bioprinting technology can be found in the published research at BioMed Central.

#bioprinting #cancerresearch #additivemanufacturing

3D bioprinting is suitable for creating 3D culture systems and macroscale clinical applications. In addition, it can print structures that are suitable for insertion into tumor resection sites. By forming macropores through 3D bioprinting, it is possible to transport oxygen, nutrients, and IL-2 cytokines, which are essential for cell survival and expansion. 3D bioprinting has potential as an off-the-shelf product platform because its automatic processing is faster than hanging drop or other seeding methods.

eandt.theiet.org/...

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
2 August 2023

"Natural Killers" Enhanced By 3D Printing

UK Food, Drugs, Healthcare, Life Sciences
Contributor
Marks & Clerk is one of the UK’s foremost firms of Patent and Trade Mark Attorneys. Our attorneys and solicitors are wired directly into the UK’s leading business and innovation economies. Alongside this we have offices in 9 international locations covering the EU, Canada and Asia, meaning we offer clients the best possible service locally, nationally and internationally.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More